Skip to main content
Log in

Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1

  • Molecular Toxicology
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

An Erratum to this article was published on 17 May 2013

Abstract

Products containing synthetic cannabinoids are consumed as a surrogate for marihuana due to their non-detectability with commonly used drug tests and their strong cannabimimetic effects. Because data concerning their toxicological properties are scarce, the cytotoxic, genotoxic, immunomodulatory, and hormonal activities of four naphthoylindole compounds (JWH-018, JWH-073, JWH-122 and JWH-210) and of one benzoylindole (AM-694) were studied in human cell lines and primary cells; tetrahydrocannabinol was included as the classical non-endogenous cannabinoid receptor ligand. All compounds induced damage to the cell membranes of buccal (TR146) and breast (MCF-7) derived cells at concentrations of ≥75–100 μM. No cytotoxic responses were seen in other assays which reflect mitochondrial damage, protein synthesis, and lysosomal activities. JWH-073 and JWH-122 induced DNA migration in buccal and liver cells (HepG2) in single cell gel electrophoresis assays, while JWH-210 was only in the latter cell line active. No estrogenic activities were detected in bone marrow cells (U2-OS), but all compounds caused anti-estrogenic effects at levels between 2.1 and 23.0 μM. Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and JWH-122 which caused a decrease of TNFα and IL-12/23p40. All toxic effects were observed with concentrations higher than those expected in body fluids of users. Since genotoxic effects are in general linear over a wide concentration range and the exposure levels may be higher in epithelial cells or in serum, further experimental work is required to find out if DNA damage takes place in drug users.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

LDHe:

Extracellular lactate dehydrogenase

IL:

Interleukin

NR:

Neutral red

SRB:

Sulforhodamine B

SCGE:

Single cell gel electrophoresis

TNFα:

Tumor necrosis factor α

XTT:

2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide

References

  • Bartek J (2011) DNA damage response, genetic instability and cancer: from mechanistic insights to personalized treatment. Mol Oncol 5(4):303–307

    Article  PubMed  CAS  Google Scholar 

  • Berryman SH, Anderson RA Jr, Weis J, Bartke A (1992) Evaluation of the co-mutagenicity of ethanol and delta 9-tetrahydrocannabinol with Trenimon. Mutat Res 278(1):47–60

    Article  PubMed  CAS  Google Scholar 

  • Brooks SC, Locke ER, Soule HD (1973) Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248(17):6251–6253

    PubMed  CAS  Google Scholar 

  • Brosin A, Wolf V, Mattheus A, Heise H (1997) Use of XTT-assay to assess the cytotoxicity of different surfactants and metal salts in human keratinocytes (HaCaT). A feasible method for in vitro testing of skin irritants. Acta Derm Venereol 77(1):26–28

    PubMed  CAS  Google Scholar 

  • Fattore L, Fratta W (2011) Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 5:60

    Article  PubMed  CAS  Google Scholar 

  • Fischer-Stenger K, Dove Pettit DA, Cabral GA (1993) Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events. J Pharmacol Exp Ther 267(3):1558–1565

    PubMed  CAS  Google Scholar 

  • Florea AM, Busselberg D (2008) Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells. Toxicol Lett 179(1):34–42

    Article  PubMed  CAS  Google Scholar 

  • Fotakis G, Timbrell JA (2006) In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 160(2):171–177

    Article  PubMed  CAS  Google Scholar 

  • Germain N, Boichot E, Advenier C, Berdyshev EV, Lagente V (2002) Effect of the cannabinoid receptor ligand, WIN 55,212–2, on superoxide anion and TNF-alpha production by human mononuclear cells. Int Immunopharmacol 2(4):537–543

    Article  PubMed  CAS  Google Scholar 

  • Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL (2012) “Spice” and “k2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict 21(4):320–326

    Article  PubMed  Google Scholar 

  • Hermanns-Clausen M, Kneisel S, Szabo B, Auwarter V (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108(3):534–544. doi:10.1111/j.1360-0443.2012.04078.x

    Google Scholar 

  • Kisselev P, Schwarz D, Platt KL, Schunck WH, Roots I (2002) Epoxidation of benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 in reconstituted membranes. Effects of charge and nonbilayer phase propensity of the membrane. Eur J Biochem 269(7):1799–1805

    Article  PubMed  CAS  Google Scholar 

  • Klegeris A, Bissonnette CJ, McGeer PL (2003) Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol 139(4):775–786

    Article  PubMed  CAS  Google Scholar 

  • Klein TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5(5):400–411

    Article  PubMed  CAS  Google Scholar 

  • Klein TW, Newton C, Widen R, Friedman H (1993) Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J Pharmacol Exp Ther 267(2):635–640

    PubMed  CAS  Google Scholar 

  • Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74(4):486–496

    Article  PubMed  CAS  Google Scholar 

  • Knasmuller S, Parzefall W, Sanyal R, Ecker S, Schwab C, Uhl M, Mersch-Sundermann V, Williamson G, Hietsch G, Langer T, Darroudi F, Natarajan AT (1998) Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res 402(1–2):185–202

    PubMed  CAS  Google Scholar 

  • Knasmuller S, Mersch-Sundermann V, Kevekordes S, Darroudi F, Huber WW, Hoelzl C, Bichler J, Majer BJ (2004) Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 198(1–3):315–328

    Article  PubMed  CAS  Google Scholar 

  • Kneisel S, Auwarter V (2012) Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid–liquid extraction. J Mass Spectrom 47(7):825–835

    Article  PubMed  CAS  Google Scholar 

  • Koskinen M, Plna K (2000) Specific DNA adducts induced by some mono-substituted epoxides in vitro and in vivo. Chem Biol Interact 129(3):209–229

    Article  PubMed  CAS  Google Scholar 

  • Lindl T, Bauer J (1989) Zell- und Gewebekultur. Stuttgart

  • Lutz WK (2000) A true threshold dose in chemical carcinogenesis cannot be defined for a population, irrespective of the mode of action. Hum Exp Toxicol 19(10):566–568 (discussion 571–562)

    Article  PubMed  CAS  Google Scholar 

  • Maines MD (1998) In vitro methods for detecting cytotoxicity in current protocols in toxicology. Wiley, Hoboken

    Google Scholar 

  • Majer BJ (2003) New hope for laboratory animals: in vitro genotoxicity tests with human hepatoma cell lines detect human food carcinogens. Formal- und Naturwissenschaftliche Fakultät

  • Mir A, Obafemi A, Young A, Kane C (2011) Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics 128(6):e1622–e1627

    Article  PubMed  Google Scholar 

  • Monnet-Tschudi F, Hazekamp A, Perret N, Zurich MG, Mangin P, Giroud C, Honegger P (2008) Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures. Toxicol Appl Pharmacol 228(1):8–16

    Article  PubMed  CAS  Google Scholar 

  • Morishima A (1984) Effects of cannabis and natural cannabinoids on chromosomes and ova. NIDA Res Monogr 44:25–45

    PubMed  CAS  Google Scholar 

  • Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99(3):403–413

    Article  PubMed  CAS  Google Scholar 

  • Nandhakumar S, Parasuraman S, Shanmugam MM, Rao KR, Chand P, Bhat BV (2011) Evaluation of DNA damage using single-cell gel electrophoresis (Comet Assay). J Pharmacol Pharmacother 2(2):107–111

    Article  PubMed  CAS  Google Scholar 

  • Okey AB, Truant GS (1975) Cannabis demasculinizes rats but is not estrogenic. Life Sci 17(7):1113–1117

    Article  PubMed  CAS  Google Scholar 

  • Rawitch AB, Schultz GS, Ebner KE, Vardaris RM (1977) Competition of delta 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding. Science 197(4309):1189–1191

    Article  PubMed  CAS  Google Scholar 

  • Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3(7):1125–1131

    Article  PubMed  CAS  Google Scholar 

  • Rupniak HT, Rowlatt C, Lane EB, Steele JG, Trejdosiewicz LK, Laskiewicz B, Povey S, Hill BT (1985) Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst 75(4):621–635

    PubMed  CAS  Google Scholar 

  • Saemann MD, Bohmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C, Stockl J, Horl WH, Zlabinger GJ (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12/23p40 and up-regulation of IL-10 production. Faseb J 14(15):2380–2382

    PubMed  CAS  Google Scholar 

  • Seely KA, Lapoint J, Moran JH, Fattore L (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 39(2):234–243. doi:10.1016/j.pnpbp.2012.04.017

    Google Scholar 

  • Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82(13):1107–1112

    Article  PubMed  CAS  Google Scholar 

  • Takeda S, Yamaori S, Motoya E, Matsunaga T, Kimura T, Yamamoto I, Watanabe K (2008) Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling. Toxicology 245(1–2):141–146

    Article  PubMed  CAS  Google Scholar 

  • Teske J, Weller JP, Fieguth A, Rothamel T, Schulz Y, Troger HD (2010) Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878(27):2659–2663

    Article  PubMed  CAS  Google Scholar 

  • Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35(3):206–221

    Article  PubMed  CAS  Google Scholar 

  • Tomiyama K, Funada M (2011) Cytotoxicity of synthetic cannabinoids found in “Spice” products: the role of cannabinoid receptors and the caspase cascade in the NG 108–15 cell line. Toxicol Lett 207(1):12–17

    Article  PubMed  CAS  Google Scholar 

  • UNODC (2011) Synthetic cannabinoids in herbal products. http://www.unodc.org/documents/scientific/Synthetic_Cannabinoids.pdf

  • van der Burg B, Winter R, Weimer M, Berckmans P, Suzuki G, Gijsbers L, Jonas A, van der Linden S, Witters H, Aarts J, Legler J, Kopp-Schneider A, Bremer S (2010) Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds. Reprod Toxicol 30(1):73–80

    Article  PubMed  Google Scholar 

  • Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz-Laviada I (2011) Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 18(7):1099–1111

    Article  PubMed  CAS  Google Scholar 

  • Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1(3):1112–1116

    Article  PubMed  CAS  Google Scholar 

  • Vodicka P, Koskinen M, Arand M, Oesch F, Hemminki K (2002) Spectrum of styrene-induced DNA adducts: the relationship to other biomarkers and prospects in human biomonitoring. Mutat Res 511(3):239–254

    Article  PubMed  CAS  Google Scholar 

  • von Bueren AO, Schlumpf M, Lichtensteiger W (2008) Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells. Anticancer Res 28(1A):85–89

    Google Scholar 

  • Wang JS, Groopman JD (1999) DNA damage by mycotoxins. Mutat Res 424(1–2):167–181

    PubMed  CAS  Google Scholar 

  • Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80(15):1415–1419

    Article  PubMed  CAS  Google Scholar 

  • Winter HK, Ehrlich VA, Grusch M, Lackner A, Schulte-Hermann R, Grasl-Kraupp B, Mikulits W, Knasmuller S (2008) Use of four new human-derived liver-cell lines for the detection of genotoxic compounds in the single-cell gel electrophoresis (SCGE) assay. Mutat Res 657(2):133–139

    Article  PubMed  CAS  Google Scholar 

  • Zhang Q, Ma P, Cole RB, Wang G (2006) Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Anal Bioanal Chem 386(5):1345–1355

    Article  PubMed  CAS  Google Scholar 

  • Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K (2009) Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Dtsch Arztebl Int 106(27):464–467

    PubMed  Google Scholar 

Download references

Acknowledgments

This study was conducted in the frame of the project “Spice and synthetic cannabinoids” (JUST/2009/DPIP/AG/0948) and was financially supported by the EU Commission, the German Ministry of Health and the City of Frankfurt/Main. Furthermore, the authors are thankful to. P. Behnisch and H. Besselink (BioDetection Systems BV, The Netherlands) for their support in regard to the realization of the estrogen measurements.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Siegfried Knasmueller.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 44 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koller, V.J., Zlabinger, G.J., Auwärter, V. et al. Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1 . Arch Toxicol 87, 1287–1297 (2013). https://doi.org/10.1007/s00204-013-1029-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-013-1029-1

Keywords

Navigation